Showing results (1-10 of 30) with videos related to
Sort By:
Pageof 3
Fortschritte Der Neurologie-Psychiatrie|August 19, 2024
[Ofatumumab in the treatment of multiple sclerosis - A summary of preclinical and clinical data]Juliane Klehmet, Tobias BoppBMC Neurology|May 26, 2023
Fatigue, depression, and product tolerability during long-term treatment with intravenous immunoglobulin (Gamunex® 10%) in patients with chronic inflammatory demyelinating polyneuropathyJuliane Klehmet, Björn Tackenberg, Judith Haas, et al.Journal of the Neurological Sciences|August 20, 2016
Stroke induces specific alteration of T memory compartment controlling auto-reactive CNS antigen-specific T cell responsesJuliane Klehmet, Sarah Hoffmann, Gerrit Walter, et al.Journal of Clinical Apheresis|May 10, 2017
A prospective study comparing tryptophan immunoadsorption with therapeutic plasma exchange for the treatment of chronic inflammatory demyelinating polyneuropathyIna Lieker, Torsten Slowinski, Lutz Harms, et al.Neuroimmunomodulation|April 14, 2006
Mouse strains differ in their susceptibility to poststroke infectionsOlaf Schulte-Herbrüggen, Juliane Klehmet, David Quarcoo, et al.Journal of Neuroimmunology|May 26, 2015
Circulating lymphocyte and T memory subsets in glucocorticosteroid versus IVIG treated patients with CIDPJuliane Klehmet, Max Staudt, Lena Ulm, et al.Clinical Neurology and Neurosurgery|October 5, 2007
Neuromyelitis optica in a patient with an early onset demyelinating episode: clinical and autoantibody findingsAnja-Maria Beyer, Klaus-Peter Wandinger, Eberhard Siebert, et al.Therapeutic Advances in Neurological Disorders|December 18, 2023
Pregnancy outcomes in female multiple sclerosis patients exposed to intramuscular interferon beta-1a or peginterferon beta-1a reported in a German Patient Support Programme - results from the non-interventional post-authorization safety study PRIMAJuliane Klehmet, Yvonne Begus-Nahrmann, Kirsi Taipale, et al.Frontiers in Neurology|September 30, 2021
Calprotectin in Chronic Inflammatory Demyelinating Polyneuropathy and Variants-A Potential Novel Biomarker of Disease ActivityFrauke Stascheit, Benjamin Hotter, Sarah Klose, et al.Multiple Sclerosis and Related Disorders|July 2, 2023
Impact of interferon beta exposure on birth outcome and child development - Results from the post-authorisation safety study PRIMAJuliane Klehmet, Yvonne Begus-Nahrmann, Kirsi Taipale, et al.Pageof 3